Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies

We present a comparative study on 124 patients with hematologic malignancies who had undergone reduced-intensity conditioning and then received a transplant from an HLA-matched related (MRD), an HLA-matched unrelated (MUD), or an HLA-haploidentical related (HAPLO) donor. The conditioning regimen, wh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kanda, Junya, Long, Gwynn D., Gasparetto, Cristina, Horwitz, Mitchell E., Sullivan, Keith M., Chute, John P., Morris, Ashley, Shafique, Michael, Li, Zhiguo, Chao, Nelson J., Rizzieri, David A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4140655/
https://ncbi.nlm.nih.gov/pubmed/24269380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.11.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars